Jeff Liter, MBA, Luminary Therapeutics, Minneapolis, MN, provides his highlights from Advanced Therapies Week 2022, including advances in allogeneic therapy manufacturing. He discusses developments that have led to more consistent donor material and media expansion techniques, as well as the cooperation between various companies to propel progress in the field. This interview took place at Advanced Therapies Week 2022.